In an oxygen-induced retinopathy model, intravitreal injection of Sema3E selectively suppressed extraretinal vascular outgrowth without affecting the desired regeneration of the retinal vasculature, indicating the therapeutic potential of Sema3E–Plexin-D1 signaling in retinopathy. The gene discussed is SEMA3E; the disease is retinal disorder.